Marketplace / Healthtech / Pre-Seed
Scyntek
“Revolutionizing vascular health monitoring through innovative, at-home DVT detection.”
Overview
Scyntek is a MedTech startup developing a non-invasive, at-home early detection system for deep vein thrombosis (DVT). The company utilizes photoplethysmography (PPG) sensor technology to empower patients to monitor their vascular health and reduce reliance on costly clinical diagnostic procedures.
Traction
as reported by the founderSelected to represent UNC-Chapel Hill at the 2025 ACC InVenture Prize; received funding from NC State’s Wolf Den Competition, UNC-Chapel Hill’s 1789 Student Venture Fund, and Launch Chapel Hill.
Deep vein thrombosis (DVT) affects up to 900,000 people annually in the U.S., but current detection methods are expensive, require clinical visits, and often fail to identify early warning signs.
Scyntek provides a non-invasive, at-home monitoring system that uses PPG sensors to detect early signs of DVT, allowing for proactive intervention before complications arise.
Company updates
No updates posted yet.
Follow this company
Get an email when Scyntek posts an update. No account needed — one click to unsubscribe.
Achievements
Scyntek
Deck · financials · founder contact